Update shared on20 Oct 2025
Fair value Increased 14%Analysts have increased the price target for Delek US Holdings from $29.62 to $33.86, reflecting improved revenue growth expectations and strategic financial adjustments.
What's in the News
- Between April 1, 2025 and August 6, 2025, Delek US Holdings repurchased 1,027,395 shares for $20.83 million. This represents 1.69% of shares outstanding (Key Developments).
- Since November 6, 2018, the company has completed the repurchase of 20,528,002 shares, totaling $579.05 million. This accounts for 29.36% of its shares (Key Developments).
Valuation Changes
- Fair Value Estimate has increased from $29.62 to $33.86, reflecting a more favorable long-term outlook.
- Discount Rate has declined slightly from 6.78% to 6.78%, indicating marginally lower perceived investment risk.
- Revenue Growth projections have improved, moving from -0.91% to -0.12%, pointing to less negative expectations for future revenue.
- Net Profit Margin is expected to decrease sharply, falling from 14.89% to 1.42%.
- Future P/E Ratio has increased substantially, rising from 1.17x to 13.71x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.